DETC induces Leishmania parasite killing in human in vitro and murine in vivo models: a promising therapeutic alternative in Leishmaniasis.
<h4>Background</h4>Chemotherapy remains the primary tool for treatment and control of human leishmaniasis. However, currently available drugs present serious problems regarding side-effects, variable efficacy, and cost. Affordable and less toxic drugs are urgently needed for leishmaniasi...
Guardado en:
Autores principales: | Ricardo Khouri, Fernanda Novais, Gisélia Santana, Camila Indiani de Oliveira, Marcos André Vannier dos Santos, Aldina Barral, Manoel Barral-Netto, Johan Van Weyenbergh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7ffd4493ecd64ce2b5d1592654528b9c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vaccination with L. infantum chagasi nucleosomal histones confers protection against new world cutaneous leishmaniasis caused by Leishmania braziliensis.
por: Marcia W Carneiro, et al.
Publicado: (2012) -
Unveiling Cerebral Leishmaniasis: parasites and brain inflammation in Leishmania donovani infected mice
por: Guilherme D. Melo, et al.
Publicado: (2017) -
Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severity.
por: Bruno B Andrade, et al.
Publicado: (2010) -
Towards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11
por: Santos DM, et al.
Publicado: (2012) -
Neutrophils reduce the parasite burden in Leishmania (Leishmania) amazonensis-infected macrophages.
por: Erico Vinícius de Souza Carmo, et al.
Publicado: (2010)